Jennifer A Sculley,Lynn B Gerald,Angelica C Scanzera et al.
Jennifer A Sculley et al.
Martin R Miller
Martin R Miller
J Henry Brems,Aparna Balasubramanian,Meredith C McCormack
J Henry Brems
Duration and Frequency of Spirometry Needed to Accurately Reflect Annualized Change of FEV1 in Chronic Obstructive Pulmonary Disease [0.03%]
用于准确反映慢性阻塞性肺疾病患者FEV₁年变化的肺功能检查时间间隔和频率研究
Jared D Wilkinson,Holly Wilhalme,Christopher B Cooper et al.
Jared D Wilkinson et al.
Rationale: The slope of decline in forced expiratory volume in 1 second (FEV1) is commonly used to reflect the rate of disease progression for descriptive studies and therapeutic trials in chronic obstructive pulmonary disease (COPD). The f...
Randomized Controlled Trial
Annals of the American Thoracic Society. 2024 Dec;21(12):1706-1714. DOI:10.1513/AnnalsATS.202401-099OC 2024
Sex-based Differences in the Use of Best Practices in Mechanically Ventilated Adults in the Intensive Care Unit: An Analysis of the Toronto Multicenter iCORE Database [0.03%]
基于多中心机械通气数据库分析重症监护病房成人患者最佳实践行为的性别差异：一项多中心研究
Sangeeta Mehta,Christopher Yarnell,Ruxandra Pinto et al.
Sangeeta Mehta et al.
Rationale: Patients who are critically ill and require admission to an intensive care unit (ICU) should receive the same quality of care regardless of their sex. Objectives: To determine, using population data from a multicenter database in...
Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial [0.03%]
吸入一氧化氮治疗肺纤维化疾病的随机、双盲、安慰剂对照试验
Steven D Nathan,Natasa Rajicic,Rosemarie Dudenhofer et al.
Steven D Nathan et al.
Rationale: Inhaled nitric oxide (iNO) has been shown to result in benefits in moderate to vigorous physical activity (MVPA) in patients with fibrotic interstitial lung disease (f-ILD) receiving supplemental oxygen in two independent trials....
Sunjay R Devarajan,Kristen A Staggers,Tianshi D Wu et al.
Sunjay R Devarajan et al.
Use of Pulmonary Rehabilitation after Chronic Obstructive Pulmonary Disease Hospitalization: An Analysis of Statewide Patient and Hospital Data [0.03%]
慢性阻塞性肺病住院患者康复后的肺康复使用情况——基于全州范围患者的医院数据分析
Whitney W Fu,Kristen P Hassett,Wassim W Labaki et al.
Whitney W Fu et al.
Rationale: Pulmonary rehabilitation (PR) is a clinically effective and cost-effective outpatient treatment for chronic obstructive pulmonary disease (COPD) that remains highly underused. Existing analyses of PR use patterns have been focuse...
Blood Transcriptomic and Inflammatory Protein Biomarkers Associated with Imminent Pulmonary Exacerbation Risk in Cystic Fibrosis [0.03%]
与囊性纤维化患者即将发生肺部急性加重相关的血液转录组和炎症蛋白生物标志物
Kang Dong,Jiah Jang,Casey P Shannon et al.
Kang Dong et al.
Rationale: The factors that lead to poor pulmonary exacerbation (PEx) outcomes in individuals with cystic fibrosis (CF) are still being investigated; however, delayed diagnosis and treatment are likely contributory. Identifying individuals ...
Interstitial Lung Disease Patients' Global Impressions of Symptoms, Severity Ratings, and Meaningfulness of Changes Over Time [0.03%]
间质性肺病患者的总体症状印象、严重程度评分及随时间变化的意义评估
Jeffrey J Swigris,Joseph B Pryor,Kerri I Aronson et al.
Jeffrey J Swigris et al.
Rationale: In interstitial lung disease (ILD), symptoms drive impairments in health-related quality of life. Patient-reported outcome measures (PROMs) can assess whether interventions change symptom severity. The meaningfulness of change in...